Skip to main navigation Skip to search Skip to main content

Incidence, risk and protective factors of symptoms after colonoscopy

  • Giulia Collatuzzo
  • , Paolo Boffetta
  • , Franco Radaelli
  • , Sergio Cadoni
  • , Cesare Hassan
  • , Leonardo Frazzoni
  • , Andrea Anderloni
  • , Liboria Laterza
  • , Marina La Marca
  • , Francesca Rogai
  • , Cecilia Binda
  • , Amedeo Montale
  • , Paola Soriani
  • , Carlo Fabbri
  • , Marco Sacco
  • , Paolo Gallittu
  • , Donatella Mura
  • , Cristina Trovato
  • , Giovanna Vitale
  • , Alessandro Mussetto
  • Alessandro Musso, Clara Benedetta Conti, Mauro Manno, Alessandro Repici, Rocco Maurizio Zagari, Andrea Farioli, Lorenzo Fuccio
  • University of Bologna
  • Ospedale Valduce
  • Centro Traumatologico-Ortopedico Hospital
  • IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
  • Humanitas University
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • IRCCS Azienda Unità Sanitaria Locale di Reggio Emilia
  • University of Florence
  • Forli-Cesena Hospital
  • Azienda USL di Modena
  • Azienda Ospedaliera - Universitaria Città della Salute e della Scienza di Torino
  • IRCCS Istituto Europeo di Oncologia - Milano
  • Azienda Ospedaliera Regionale “S. Carlo”
  • Ospedale S. Maria delle Croci
  • ASST-Monza

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Background: Few studies focused on minor adverse events which may develop after colonoscopy. Aims: To investigate the incidence and factors associated to post-colonoscopy symptoms. Methods: This is a prospective study conducted in 10 Italian hospitals. The main outcome was a cumulative score combining 10 gastrointestinal (GI) symptoms occurring the week following colonoscopy. The analyses were conducted via multivariate logistic regression. Results: Of 793 subjects included in the analysis, 361 (45.5%) complained the new onset of at least one GI symptom after the exam; one symptom was reported by 202 (25.5%), two or more symptoms by 159 (20.1%). Newly developed symptoms more frequently reported were epigastric/abdominal bloating (32.2%), pain (17.3%), and dyspeptic symptoms (17.9%). Symptoms were associated with female sex (odds ratio [OR]=2.54), increasing number of symptoms developed during bowel preparation intake (OR=1.35) and somatic symptoms (OR=1.27). An inverse association was observed with better mood (OR=0.74). A high-risk profile was identified, represented by women with bad mood and somatic symptoms (OR=8.81). Conclusion: About half of the patients develop de novo GI symptoms following colonoscopy. Improving bowel preparation tolerability may reduce the incidence of post-colonoscopy symptoms, especially in more vulnerable patients.

Original languageEnglish
Pages (from-to)1698-1705
Number of pages8
JournalDigestive and Liver Disease
Volume54
Issue number12
DOIs
StatePublished - Dec 2022

Keywords

  • Bowel preparation
  • Colonoscopy
  • Colonoscopy experience
  • Post-colonoscopy symptoms

Fingerprint

Dive into the research topics of 'Incidence, risk and protective factors of symptoms after colonoscopy'. Together they form a unique fingerprint.

Cite this